Screener
Eligibility screening
Testing a Combination of DS-8201a and Olaparib in HER2-Expressing Cancers
5 US sites in AZ, FL, MA, MN +1
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Testing a Combination of DS-8201a and Olaparib in HER2-Expressing Cancers
5 US sites in AZ, FL, MA, MN +1
Before we begin
Your answer affects how the questions are phrased.